newsfilter
← Latest News
Business Wire·

QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale

QTI
  • QT Imaging reported second-quarter 2026 revenue of $7.4 million, a 103% increase year-over-year, with first-half revenue rising 116% to $14.0 million.
  • The company shipped 15 Breast Acoustic CT scanners in the second quarter and 28 scanners during the first six months of 2026.
  • QT Imaging completed a $10.0 million public offering to strengthen its capital position and extended its senior secured term loan maturity to March 31, 2029.
  • The company expanded its direct U.S. commercial organization by appointing regional sales vice presidents to accelerate adoption alongside distribution partners.
  • QT Imaging received regulatory authorization in Israel via AMAR clearance and FDA clearance in Saudi Arabia, while pursuing further approvals in the Gulf region and Europe.
  • The company successfully completed its first routine FDA inspection with zero Form 483 observations, indicating a strong quality management system.
  • A multi-site study demonstrated less than 1% variability in Speed of Sound measurements across scanners, supporting the use of quantitative imaging biomarkers.
  • QT Imaging moved to a new 22,000-square-foot manufacturing facility in Petaluma, CA, which offers over 2.5 times the previous operational space while reducing lease costs by approximately 55%.
  • The company appointed Dr. Julia Albright as Chief Science Officer and Dr. Barry Roseman as Senior Medical Advisor to strengthen clinical leadership.
  • Second-quarter operating expenses increased to $4.9 million from $2.9 million the prior year, driven by higher employee compensation, professional services, and marketing costs.
  • QT Imaging reported a second-quarter net loss of $11.1 million, or $0.75 per share, compared to a net loss of $4.0 million, or $0.42 per share, in the prior-year quarter.
  • A significant $8.3 million non-cash loss on debt extinguishment related to the Lynrock Lake term loan modification contributed to higher interest expenses in the quarter.
  • The company reaffirmed its full-year 2026 revenue guidance of approximately $39 million based on distribution agreements and direct sales efforts.
  • As of June 30, 2026, QT Imaging held $11.0 million in cash and restricted cash, which increased to $14.2 million by August 7, 2026.